Atlanta Lawyers Eye Trials of COVID-19 Drug After 'Mad Scramble' for IP Deal

Daily Report: Atlanta Lawyers Eye Trials of COVID-19 Drug After 'Mad Scramble' for IP Deal

May 07, 2020

United States
United States
United States

Eversheds Sutherland Partner Peter Quittmeyer is quoted in this article by Law.com's Daily Report discussing his licensing work for client DRIVE (Drug Innovation Ventures at Emory). Peter represented DRIVE in a licensing agreement with Ridgeback Biotherapeutics LP to rapidly advance DRIVE's EIDD-2801, a promising oral COVID-19 treatment, into human testing.

He told the Daily Report that he is used to clients moving very fast, but "there was definitely an urgency to this." He estimated that the parties had 90% of their issues agreed upon when negotiations started.

"Everyone knew you were talking about, potentially, lives" at stake, he said.

He added that Emory’s technology transfer team, which had to work on a host of federal and university requirements, "really turned it around in miraculous time."

 

The materials on the Eversheds Sutherland website are for general information purposes only and do not constitute legal advice. While reasonable care is taken to ensure accuracy, the materials may not reflect the most current legal developments. Eversheds Sutherland disclaims liability for actions taken based on the materials. Always consult a qualified lawyer for specific legal matters. To view the full disclaimer, see our Terms and Conditions or Disclaimer section in the footer.

Services

Latest Insights

Latest News

Latest Events

skyscrapers upward view modern city glass buildings corporate architecture

legal updates

June 02, 2026

Illinois tax increases part two: Digital asset privilege tax, prediction ma...

Curved building with hexagonal patterned glass

legal updates

June 01, 2026

Illinois tax increases part one: Digital services taxes

shopping district

legal updates

May 29, 2026

Consumer Lens - Session 1 | The Rise of European Class Actions

Business meeting close up discussing data

podcasts and webcasts

May 29, 2026

Tax NOLs in Cross-Border Structures Webinar

© 2026 Eversheds Sutherland (US) LLP

Eversheds Sutherland is the name and brand under which the members of Eversheds Sutherland Limited (Eversheds Sutherland (International) LLP and Eversheds Sutherland (US) LLP) and their respective controlled, managed or affiliated firms and the members of Eversheds Sutherland (Europe) Limited and Eversheds Sutherland (Africa) Limited (each an "Eversheds Sutherland Entity" and together the "Eversheds Sutherland Entities") provide legal or other services to clients around the world. Eversheds Sutherland Entities are constituted and regulated in accordance with relevant local regulatory and legal requirements. The use of the name Eversheds Sutherland, is for description purposes only and does not imply that the member firms or their controlled, managed or affiliated entities are in a partnership or are part of a global entity. The responsibility for the provision of services to the client is defined in the terms of engagement between the instructed firm and the client. For information on Konexo please also see the Legal Notices page of this website
ATTORNEY ADVERTISING - Prior results do not guarantee a similar outcome.
Unless otherwise indicated, attorneys at Eversheds Sutherland (US) LLP are not certified by the Texas Board of Legal Specialization.